Amid the wave of health consumption upgrades, how can technological means address the "one-size-fits-all" pain point in nutritional supplementation? Recently, at an industry interview event hosted by the Transfar Sci-Tech City Coffee Talk program, Cai Yi, Chairman of ASXAN Biotech Group, was invited to attend and engaged in in-depth discussions with industry experts on industrial trends. As an international microalgae nutrition supplier dedicated to "revitalizing every cell with technology," Cai explicitly stated during the interview that ASXAN Biotech Group is relying on synthetic biology technology, with core products such as AstaMAZ® and FucoSLIM® as support, to build a global microalgae nutrition ecosystem with a "Chinese Core."
Breaking the "One-Size-Fits-All" Model: The Upgrade Battle from "General Supplementation" to "Precision Customization"
With the awakening of consumer health awareness, general nutritional supplements can no longer meet segmented market demands. Cai emphasized in the interview that Precision Nutrition is the inevitable direction for industry evolution, and technological breakthroughs in core products are the key support for achieving this direction.
"Future nutritional interventions must be 'tailored to individuals.' The core lies in providing customized nutritional solutions for the health pain points of different populations. Services have already emerged that obtain physiological data through family doctors or continuous monitoring devices, and then professional brands deliver personalized formulas on demand," Cai said. He added that ASXAN Biotech Group, relying on its three innovative research platforms—"Synthetic Biology," "Nutritional Ecology," and "Digital Intelligence Brand"—is focusing on diverse segmented health needs worldwide. The R&D of FucoSLIM® fucoxanthin, for instance, is a personalized achievement targeting metabolic health and weight management. This functional nutrient precisely enters the weight management and metabolic health track. With the help of synthetic biology technology, it achieves efficient extraction and activity retention, providing targeted solutions for groups with metabolic regulation and weight control needs, becoming a typical carrier for the company to practice the concept of "precision nutrition."
The company is no longer limited to the R&D of single products. Instead, it is building a product matrix covering different health needs with AstaMAZ® and FucoSLIM® as the core, thereby exploring "personalized customization plans" based on individual physiological data, lifestyles, and specific health demands. Through the deep integration of digital health management and biotechnology, it matches precise nutritional combinations for different groups—for example, pairing AstaMAZ® astaxanthin for those with antioxidant and anti-inflammatory needs, and customizing FucoSLIM®-related plans for metabolic management groups—truly achieving the upgrade from "general products" to "personalized services" and leading the industry's transformation from "selling products" to "selling health solutions."
Technology Implementation and Brand Globalization: Verifying the Industrial Value of the "Chinese Core" with Core Products
Under the precision nutrition strategy, ASXAN Biotech Group's technological achievements have been industrialized through multiple core products, with AstaMAZ® New Zealand Natural Astaxanthin being a benchmark case. Cai introduced that this New Zealand-origin natural astaxanthin, adopting New Zealand's cutting-edge supercritical extraction technology, redefines industry standards for astaxanthin with its high purity, high activity, and natural safety. It has obtained certifications from international authoritative bodies such as the U.S. FDA and the European Food Safety Authority (EFSA), and achieved multi-scenario applications.
In the agricultural food sector, for example, ASXAN Biotech Group applied astaxanthin to functional feed formulas, successfully empowering traditional aquaculture. This not only enhanced the added value of agricultural products but also provided a replicable technological path for "food-based health preservation." At the same time, the product has been extended to dietary supplements, medical beauty assistance, and other fields, demonstrating the diversified empowerment potential of synthetic biology technology.
"We are determined to build an international nutritional brand matrix with a 'Chinese Core'," Cai said firmly. Currently, ASXAN Biotech Group has built a product system centered on AstaMAZ® natural astaxanthin, FucoSLIM® fucoxanthin, and AlgaeOmega® algal oil. Relying on its independently developed ATPS (Aqueous Two-Phase System) microalgae photobiological cell synthesis technology, it has broken international monopolies and promoted Chinese microalgae nutrition technology to the global market. This invitation to share not only demonstrated the company's profound scientific research accumulation and product strength but also highlighted the determination and confidence of Chinese enterprises to move from "following" to "keeping pace" and even "leading" in the big health track.
In the future, ASXAN Biotech Group will continue to uphold the original aspiration of "born for love, moving forward with love." With synthetic biology technology as the core, it will deepen the iteration and innovation of products such as AstaMAZ® and FucoSLIM®, helping humans explore the source code of life with transparent, authentic, and warm technological power, and bringing a more technologically advanced healthy living experience to consumers worldwide.